Join us for the 6th Annual diaTribe Musings Panel Discussions
Thursday, September 2, 2021
Diabetes Data: A Roadmap to Better Management
6:30-8:15pm EDT / 3:30-5:15pm PDT
The last five years have generated more data from people living with diabetes than the prior fifty. This explosion of data is driving changes in everything from personal behavior to therapy and technology, transforming the landscape of diabetes care. Data is no longer mainly for engineers and researchers, it’s a tool all of us use everyday! How we use and produce data has transformed modern life living and working with diabetes, in both obvious and hidden ways. Many are working with this data, developing new ways for improving diabetes care. From patients interpreting their basic glucose monitoring data and using more advanced glucose profiles that contextualize A1c, to global data efforts that seek to expand life-saving care over diverse and disparate populations, this data revolution is changing how we think about and treat diabetes in big and small ways.
This panel will explore questions such as, what does the collection of data mean for people with diabetes seeking to improve their health -- both for those using new digital platforms and those not? How can basic data be used to help people build care teams and develop individualized treatment plans? How can data be used to improve relationships with care partners — loved ones and friends?
Our highly-regarded speakers are Chris Boulton, Sanofi; Jeff Dachis, One Drop; Holly McGarraugh, McGarraugh Consulting; and David Price, Dexcom. The panel will be moderated by diaTribe Founder Kelly Close. (Biographies below.)
Chris Boulton, Head of Diabetes, Sanofi US
Chris has been the Head of Diabetes for Sanofi US since April 2020. Previously Chris worked in the Global Diabetes Franchise team at Sanofi firstly as a Global Brand Lead, then heading up the Global Diabetes Digital Solutions team. Chris has worked for 25 years in the pharmaceutical industry, covering multiple roles from strategy through to large country operational roles, different therapy areas, and multiple geographies for different organizations. In that time Chris has enjoyed working with incredibly talented people passionate to make a difference to the lives of patients and has been fortunate to live and work in the US, Europe and Australia.
Jeff Dachis, CEO and Founder, One Drop
Jeff Dachis is the CEO and founder of One Drop, a precision health company harnessing the power of continuous health sensing technology and artificial intelligence to deliver personalized, preventative care to people with chronic conditions worldwide. After Jeff was diagnosed with type 1 diabetes, he set out to create a proactive self-care solution that would revolutionize the way people think about their health. As a result, One Drop was born in 2015. Since then, Jeff has successfully led One Drop through Series C financing, expanded the company beyond its direct-to-consumer roots by introducing the One Drop employer program, and began developing the One Drop biosensor. Today, One Drop's predictive health platform supports people with prediabetes, diabetes, high blood pressure, and high cholesterol, with plans to expand into cardiology, women's health, and other therapeutic areas. Jeff is a digital visionary and serial entrepreneur. He is the co-founder, former CEO, and chairman of Razorfish—now part of Publicis Groupe and one of the world's largest interactive agencies—which he led through a successful $55MM IPO in 1999. He later founded the Dachis Group, ultimately acquired by Sprinklr in 2014, with the vision of unlocking the value of a social business for large corporate enterprises and brands. Considered one of the early pioneers in the development of the internet, Jeff helped create the first banner ad and web animation; the San Francisco Museum of Modern Art exhibits his digital work as part of their permanent collection. Today, Jeff is driven by One Drop's mission to transform health, change lives, and create new opportunities for everyone.
David Price, MD, Vice President of Medical Affairs, Dexcom
Dr. Price's responsibilities at Dexcom have included leading the strategy, design, and interpretation of clinical trials and usability studies, developing and executing publication strategies, supporting investigator-initiated studies, and providing medical input into product development and risk management processes. Dr. Price leads clinical discussions with regulators, advocacy groups, professional societies, payers and strategic accounts. He successfully led the Dexcom team in a FDA advisory panel meeting to expand the indication for Dexcom CGM to replace BG measurements for diabetes management. He ideated and led the steering committees for the DIAMOND and MOBILE Studies that established the value of CGM in diverse insulin users. Dr. Price previously worked at LifeScan and was responsible for developing clinical decision support solutions and leading the clinical research program. Dr. Price received his undergraduate baccalaureate degree from Washington University in St. Louis and his medical degree from the Ohio State University. He completed his internship and internal medicine residency at the Maine Medical Center and a clinical fellowship at the Joslin Diabetes Center and Harvard Medical School. Dr. Price serves on the Board of Directors of the Behavioral Diabetes Institute.
Kelly L. Close, Founder, The diaTribe Foundation & President, Close Concerns
Kelly is the founder and Chair of the Board of The diaTribe Foundation, a nonprofit dedicated to improving the lives of people living with diabetes and prediabetes, and advocating for action. Since 2006, she has been editor-in-chief at diaTribe.org, our free website focused on making people with diabetes healthier, happier, and more hopeful. We send diaTribe mailers weekly to over 225,000 people with diabetes and their families. Since 2002, Kelly has been leading Close Concerns, a healthcare information firm focused on diabetes, obesity, digital health, and connected care. Each year Kelly and her colleagues attend over 40 scientific and regulatory gatherings in the US and around the world, focused in these areas; they read the key medical literature in the field and write regularly about dozens of private and public companies and nonprofit organizations in the field. Kelly graduated from Amherst College and Harvard Business School and lives in San Francisco with her husband and three children. Kelly's passion for diabetes comes from her extensive professional work as well as her personal experience living with diabetes for nearly 35 years.
About diaTribe Musings
Previously known as Musings Under the Moon, when it was a single live event at the ADA Scientific Sessions, diaTribe Musings is now one of The diaTribe Foundation's most treasured ongoing virtual programs, engaging a diverse audience in thought-provoking dialogue and providing an opportunity to connect healthcare providers, business leaders, people living with diabetes, advocates, families, entrepreneurs, and policymakers. Musings tickets are complimentary thanks to the generous support of our sponsors. We welcome anyone interested in learning about the massive shifts and opportunities occurring in the world of diabetes. Please spread the word and share this event with anyone interested in learning more about diabetes. Join the conversation on Twitter with #diaTribeMusings.
Past Musings Events